When is crossover desirable in cancer drug trials and when is it problematic?

A. Haslam, V. Prasad

Research output: Contribution to journalEditorial

2 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalAnnals of Oncology
Volume29
Issue number5
DOIs
StatePublished - May 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this